Zesiewicz, TA, and RA Hauser. 2000. “Depression in Patients With Parkinson’s Disease: Epidemiology, Pathophysiology and Treatment Options. CNS Drugs 2000;13:227-304.”. CNS Drugs.
Publications
2000
Olanow, CW, and Tasmar Advisory Panel. 2000. “Tolcapone and Hepatotoxic Effects. Arch Neurol 2000:57; 263-267.”. Arch Neurol.
Hauser, RA, MN Wahba, TA Zesiewicz, , and W Anderson. 2000. “Modafinil Treatment of Pramipexole-Associated Somnolence. Mov Disord 2000;15:1269-1271.”. Mov Disord.
1999
Freeman, TB, DE Vawter, PE Leaverton, JH Godbold, RA Hauser, CG Goetz, and CW Olanow. 1999. “Use of Placebo Surgery in Controlled Trials of Cellular-Based Therapy for Parkinson’s Disease. NEJM 1999; 341:988-992.”. NEJM.
Zesiewicz, TA, M Gold, G Chari, and RA Hauser. 1999. “Depression and Anxiety in Parkinson’s Disease. American Journal of Geriatric Psychiatry. 1999;7:110-118.”. Am J Geriatr Psych.
Hauser, RA, and TA Zesiewicz. 1999. “Management of Early Parkinson’s Disease. Medical Clinics of North America 1999;83:393-414.”. Medical Clinics of North America.
Zesiewicz, TA, and RA Hauser. 1999. “Ropinirole in the Treatment of Parkinson’s Disease. Expert Opinion on Investigational Drugs 1999;8:697-710.”. Expert Opinion on Investigational Drugs.
Zesiewicz, TA, M Gold, G Chari, and RA Hauser. 1999. “Current Issues in Depression in Parkinson’s Disease. Am J Geriatr Psych 1999; :110-118.”. Am J Geriatr Psych.
Hauser, RA. 1999. “Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson’s Disease. Arch Neurol 1999;56:179-187.”. Arch Neurol.
1998
Kompoliti, K, CG Goetz, BF Boeve, RA Hauser, and . 1998. “Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration. Arch Neurol 1998; 55:957-961.”. Arch Neurol.